RPS Announces Stephen Kasay as Chief Information Officer

FORT WASHINGTON, Pa., Aug. 30, 2012 /CNW/ - ReSearch Pharmaceutical Services, Inc. (RPS), a next generation CRO that provides comprehensive global Phase 1-4 clinical development solutions to the biopharmaceutical and medical device industries, today announced that Stephen Kasay has joined the organization as Chief Information Officer.

In his role, Steve will have the responsibility for the global information technology function of RPS, including IT strategy development and optimization of technology infrastructure, software systems and enterprise data assets.

Mr. Kasay has more than thirty years of health care experience, including more than twenty years providing leadership to Information Technology departments in global pharmaceutical companies and Clinical Research Organizations. His accomplishments include the successful implementation of technology to enhance productivity and quality, the establishment of IT governance processes, the realization of successful project and program management, and the development of business engagement and communication practices to improve clinical development services.

"Steve brings significant global expertise to RPS, and we are extremely pleased to welcome him as a member of our Strategic Steering Committee and Executive Management Team. His addition will allow RPS to continue our transformation through world-class enabling technologies and to accelerate our goal of providing innovative clinical development solutions to the biopharmaceutical industry that improve quality and speed while driving down costs," said Daniel M. Perlman, Chairman and CEO.

About RPS

RPS provides comprehensive global Phase I-IV clinical development solutions to the Pharmaceutical, Biotechnology, Medical Device and Diagnostic industries. By combining our highly experienced clinical research operations infrastructure with the industry's largest resourcing engines, RPS is uniquely positioned to offer our Customers a broad spectrum of outsourcing solutions. These solutions range from globally Embedded functional and cross-functional programs to enhanced global full-service solutions, and are powered by highly experienced project teams providing innovative, seamless, cost-effective and high quality services.

With more than 5,000 employees, RPS operates in more than 64 countries across the globe.

SOURCE: ReSearch Pharmaceutical Services, Inc.

For further information:

Business Contact: Samir Shah, Executive Vice President, Strategic Development, [e-mail], +1 215.540.0700; Marketing & Media Contact: Sean P. Quinn, Director, Global Marketing, [e-mail]

http://www.rpsweb.com